
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
KSHV: Immune Modulation and Immunotherapy
Grant Broussard, Blossom Damania
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 48
Grant Broussard, Blossom Damania
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 48
Showing 1-25 of 48 citing articles:
KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine
Corey Casper, Lawrence Corey, Jeffrey I. Cohen, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 42
Corey Casper, Lawrence Corey, Jeffrey I. Cohen, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 42
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus
Kathryn Lurain, Ramya Ramaswami, Laurie T. Krug, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 3
Closed Access | Times Cited: 10
Kathryn Lurain, Ramya Ramaswami, Laurie T. Krug, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 3
Closed Access | Times Cited: 10
Microbiota Effects on Carcinogenesis: Initiation, Promotion, and Progression
Lacey R. Lopez, Rachel M. Bleich, Janelle C. Arthur
Annual Review of Medicine (2020) Vol. 72, Iss. 1, pp. 243-261
Open Access | Times Cited: 67
Lacey R. Lopez, Rachel M. Bleich, Janelle C. Arthur
Annual Review of Medicine (2020) Vol. 72, Iss. 1, pp. 243-261
Open Access | Times Cited: 67
Today's Kaposi sarcoma is not the same as it was 40 years ago, or is it?
Blossom Damania, Dirk P. Dittmer
Journal of Medical Virology (2023) Vol. 95, Iss. 5
Open Access | Times Cited: 17
Blossom Damania, Dirk P. Dittmer
Journal of Medical Virology (2023) Vol. 95, Iss. 5
Open Access | Times Cited: 17
Cancer and HIV: The Molecular Mechanisms of the Deadly Duo
Aadilah Omar, N M Marques, Nicole Crawford
Cancers (2024) Vol. 16, Iss. 3, pp. 546-546
Open Access | Times Cited: 6
Aadilah Omar, N M Marques, Nicole Crawford
Cancers (2024) Vol. 16, Iss. 3, pp. 546-546
Open Access | Times Cited: 6
SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
Jungang Chen, Lu Dai, Lindsey Barrett, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 39
Jungang Chen, Lu Dai, Lindsey Barrett, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 39
Unraveling the Kaposi Sarcoma-Associated Herpesvirus (KSHV) Lifecycle: An Overview of Latency, Lytic Replication, and KSHV-Associated Diseases
Victor A. Losay, Blossom Damania
Viruses (2025) Vol. 17, Iss. 2, pp. 177-177
Open Access
Victor A. Losay, Blossom Damania
Viruses (2025) Vol. 17, Iss. 2, pp. 177-177
Open Access
DR5 is a restriction factor for human herpesviruses
Chunyan Han, Chenwu Gui, Biyi Su, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 11
Open Access
Chunyan Han, Chenwu Gui, Biyi Su, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 11
Open Access
Disrupting the OTUD4-USP7 deubiquitinase complex to suppress herpesvirus replication: a novel antiviral strategy
Shaowei Wang, Xuezhang Tian, Yunhong Zhong, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 4, pp. e1013052-e1013052
Open Access
Shaowei Wang, Xuezhang Tian, Yunhong Zhong, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 4, pp. e1013052-e1013052
Open Access
Deciphering the roles of myeloid derived suppressor cells in viral oncogenesis
Alexander Glover, Zhang Zhao-qin, Claire Shannon‐Lowe
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Alexander Glover, Zhang Zhao-qin, Claire Shannon‐Lowe
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Applications of cell therapy in the treatment of virus-associated cancers
Keri Toner, Chase D. McCann, Catherine M. Bollard
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 10, pp. 709-724
Closed Access | Times Cited: 4
Keri Toner, Chase D. McCann, Catherine M. Bollard
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 10, pp. 709-724
Closed Access | Times Cited: 4
Kaposi’s sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda
Angela Nalwoga, Romin Roshan, Kyle Moore, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Angela Nalwoga, Romin Roshan, Kyle Moore, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Molecular Mechanisms of Kaposi Sarcoma Development
Andy Karabajakian, Isabelle Ray‐Coquard, Jean‐Yves Blay
Cancers (2022) Vol. 14, Iss. 8, pp. 1869-1869
Open Access | Times Cited: 17
Andy Karabajakian, Isabelle Ray‐Coquard, Jean‐Yves Blay
Cancers (2022) Vol. 14, Iss. 8, pp. 1869-1869
Open Access | Times Cited: 17
EZH2-Myc Hallmark in Oncovirus/Cytomegalovirus Infections and Cytomegalovirus’ Resemblance to Oncoviruses
Ranim El Baba, Georges Herbein
Cells (2024) Vol. 13, Iss. 6, pp. 541-541
Open Access | Times Cited: 3
Ranim El Baba, Georges Herbein
Cells (2024) Vol. 13, Iss. 6, pp. 541-541
Open Access | Times Cited: 3
Co-Infection of the Epstein–Barr Virus and the Kaposi Sarcoma-Associated Herpesvirus
Michelle Böni, Lisa Rieble, Christian Münz
Viruses (2022) Vol. 14, Iss. 12, pp. 2709-2709
Open Access | Times Cited: 14
Michelle Böni, Lisa Rieble, Christian Münz
Viruses (2022) Vol. 14, Iss. 12, pp. 2709-2709
Open Access | Times Cited: 14
Multifaceted roles for STAT3 in gammaherpesvirus latency revealed through in vivo B cell knockout models
Chad H. Hogan, Shana M. Owens, Glennys V. Reynoso, et al.
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 2
Chad H. Hogan, Shana M. Owens, Glennys V. Reynoso, et al.
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 2
Tumor Antigens beyond the Human Exome
Lisabeth Emilius, Franziska Bremm, Amanda Katharina Binder, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4673-4673
Open Access | Times Cited: 2
Lisabeth Emilius, Franziska Bremm, Amanda Katharina Binder, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4673-4673
Open Access | Times Cited: 2
Lymphedema and Kaposi sarcoma: A narrative review
Mathilde Dauguet, Célèste Lebbé, S. Vignes
JMV-Journal de Médecine Vasculaire (2023) Vol. 48, Iss. 5-6, pp. 181-187
Closed Access | Times Cited: 6
Mathilde Dauguet, Célèste Lebbé, S. Vignes
JMV-Journal de Médecine Vasculaire (2023) Vol. 48, Iss. 5-6, pp. 181-187
Closed Access | Times Cited: 6
Immunotherapy for KSHV-associated diseases
Kathryn Lurain, Robert Yarchoan, Ramya Ramaswami
Current Opinion in Virology (2022) Vol. 55, pp. 101249-101249
Open Access | Times Cited: 10
Kathryn Lurain, Robert Yarchoan, Ramya Ramaswami
Current Opinion in Virology (2022) Vol. 55, pp. 101249-101249
Open Access | Times Cited: 10
Proximity Biotin Labeling Reveals Kaposi’s Sarcoma-Associated Herpesvirus Interferon Regulatory Factor Networks
Ashish Kumar, Michelle Salemi, Resham Bhullar, et al.
Journal of Virology (2021) Vol. 95, Iss. 9
Open Access | Times Cited: 14
Ashish Kumar, Michelle Salemi, Resham Bhullar, et al.
Journal of Virology (2021) Vol. 95, Iss. 9
Open Access | Times Cited: 14
Novel therapeutic drug strategies to tackle immune-oncological challenges faced by cancer patients during COVID-19
Anwar Ali, Hafsa Mughal, Naz̲īr Aḥmad, et al.
Expert Review of Anticancer Therapy (2021) Vol. 21, Iss. 12, pp. 1371-1383
Closed Access | Times Cited: 14
Anwar Ali, Hafsa Mughal, Naz̲īr Aḥmad, et al.
Expert Review of Anticancer Therapy (2021) Vol. 21, Iss. 12, pp. 1371-1383
Closed Access | Times Cited: 14
Protein Degradation by Gammaherpesvirus RTAs: More Than Just Viral Transactivators
Lauren R. Combs, Jacob Combs, Robert McKenna, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 730-730
Open Access | Times Cited: 5
Lauren R. Combs, Jacob Combs, Robert McKenna, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 730-730
Open Access | Times Cited: 5
KSHV vIL-6 enhances inflammatory responses by epigenetic reprogramming
Tomoki Inagaki, Kang-Hsin Wang, Ashish Kumar, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 11, pp. e1011771-e1011771
Open Access | Times Cited: 5
Tomoki Inagaki, Kang-Hsin Wang, Ashish Kumar, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 11, pp. e1011771-e1011771
Open Access | Times Cited: 5
The ORF45 Protein of Kaposi Sarcoma-Associated Herpesvirus Is an Inhibitor of p53 Signaling during Viral Reactivation
Dina Alzhanova, James O. Meyo, Angelica Juarez, et al.
Journal of Virology (2021) Vol. 95, Iss. 23
Open Access | Times Cited: 12
Dina Alzhanova, James O. Meyo, Angelica Juarez, et al.
Journal of Virology (2021) Vol. 95, Iss. 23
Open Access | Times Cited: 12
Role of Interleukin-1 Family Members and Signaling Pathways in KSHV Pathogenesis
Lindsey Barrett, Jungang Chen, Lu Dai, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 12
Lindsey Barrett, Jungang Chen, Lu Dai, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 12